Pharming Group N.V. (PHAR)

Pharming Group Revenue

Pharming Group had revenue of $366.45M in the twelve months ending June 30, 2026, up 7.84% year-over-year. In the year 2025, Pharming Group had annual revenue of $376.13M with 26.56% growth.

• Revenue (ttm): $366.45M
• Revenue Growth: +7.84%
• P/S Ratio: 1.79
• Revenue / Employee: $900,440
• Employees: 407
• Market Cap: 639.57M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Ruconest® 317.92M 84.5%
• Joenja® 58.21M 15.5%

By Geography

Chart

• United States (US) 361.75M 96.2%
• Europe and The Rest of The World 14.39M 3.8%

Fiscal year ended Dec 31, 2025 See the full Pharming Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	376.13M	78.93M	26.56%
Dec 31, 2024	297.20M	51.88M	21.15%
Dec 31, 2023	245.32M	39.69M	19.30%
Dec 31, 2022	205.62M	6.75M	3.39%
Dec 31, 2021	198.87M	-13.30M	-6.27%
Dec 31, 2020	212.17M	22.79M	12.03%
Dec 31, 2019	189.39M	34.10M	21.96%
Dec 31, 2018	155.29M	47.75M	44.40%
Dec 31, 2017	107.54M	90.83M	543.88%
Dec 31, 2016	16.70M	4.94M	42.05%
Dec 31, 2015	11.76M	-13.88M	-54.13%
Dec 31, 2014	25.63M	16.22M	172.36%
Dec 31, 2013	9.41M	-4.59M	-32.77%
Dec 31, 2012	14.00M	10.12M	260.60%
Dec 31, 2011	3.88M	3.12M	406.76%
Dec 31, 2010	766.09K	285.75K	59.49%
Dec 31, 2009	480.35K	-445.02K	-48.09%
Dec 31, 2008	925.37K	-83.22K	-8.25%
Dec 31, 2007	1.01M	815.16K	421.44%
Dec 31, 2006	193.42K	-285.11K	-59.58%
Dec 31, 2005	478.53K	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error